Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement
Gespeichert in:
Veröffentlicht in: | Diabetes care 2014-06, Vol.37 (6), p.1745-1750 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1750 |
---|---|
container_issue | 6 |
container_start_page | 1745 |
container_title | Diabetes care |
container_volume | 37 |
creator | BUFALINO, Vincent BAUMAN, Mary Ann SHUBROOK, Jay H BALCH, Alan J BOONE, Christopher VENNUM, Katy BRADLEY, Sarah WENDER, Richard C MINNERS, Regan ARNETT, Donna |
description | |
doi_str_mv | 10.2337/dc14-0901 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1541383391</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1541383391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c280t-c6ae018f0cc7068ce8ce81c285f875a4d6cdf081129fde58a71ed4b029815acf3</originalsourceid><addsrcrecordid>eNpFkE1LxDAQhoMouq4e_AOSi6CHatIkbeJtWfyClfWwnktMJlppm5q0gv_eFFeFgRneeXgPD0InlFzmjJVX1lCeEUXoDppRxUQmBJe7aEYoV5lQKj9AhzG-E0I4l3IfHeS8lEqxYob6m0_fjEPtO-wd3rwBvhtrC03dAV7YT90N-hWu8Qpi9F1MW4cOLL4NvsVDotPRDXiV8DgVrMeh10MNKXuC4HxodWcAP4KOY4A25Udoz-kmwvF2z9Hz7c1meZ-t1ncPy8UqM7kkQ2YKDYRKR4wpSSENTEPTTzhZCs1tYawjktJcOQtC6pKC5S8kV5IKbRybo_Of3j74jxHiULV1NNA0ugM_xooKTplkTNGEXvygJvgYA7iqD3Wrw1dFSTUJribB1SQ4safb2vGlBftH_hpNwNkW0NHoxoUkoI7_nBScSJWzb7qrg9c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1541383391</pqid></control><display><type>article</type><title>Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>BUFALINO, Vincent ; BAUMAN, Mary Ann ; SHUBROOK, Jay H ; BALCH, Alan J ; BOONE, Christopher ; VENNUM, Katy ; BRADLEY, Sarah ; WENDER, Richard C ; MINNERS, Regan ; ARNETT, Donna</creator><creatorcontrib>BUFALINO, Vincent ; BAUMAN, Mary Ann ; SHUBROOK, Jay H ; BALCH, Alan J ; BOONE, Christopher ; VENNUM, Katy ; BRADLEY, Sarah ; WENDER, Richard C ; MINNERS, Regan ; ARNETT, Donna ; American Diabetes Association ; American Cancer Society ; American Heart Association ; on behalf of the American Cancer Society, American Diabetes Association</creatorcontrib><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/dc14-0901</identifier><identifier>PMID: 24789936</identifier><identifier>CODEN: DICAD2</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Biological and medical sciences ; Diabetes. Impaired glucose tolerance ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Evidence-Based Practice ; Humans ; Learning ; Medical sciences ; Metabolic diseases ; Outpatients ; Practice Guidelines as Topic ; Quality Improvement</subject><ispartof>Diabetes care, 2014-06, Vol.37 (6), p.1745-1750</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c280t-c6ae018f0cc7068ce8ce81c285f875a4d6cdf081129fde58a71ed4b029815acf3</citedby><cites>FETCH-LOGICAL-c280t-c6ae018f0cc7068ce8ce81c285f875a4d6cdf081129fde58a71ed4b029815acf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28540892$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24789936$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>BUFALINO, Vincent</creatorcontrib><creatorcontrib>BAUMAN, Mary Ann</creatorcontrib><creatorcontrib>SHUBROOK, Jay H</creatorcontrib><creatorcontrib>BALCH, Alan J</creatorcontrib><creatorcontrib>BOONE, Christopher</creatorcontrib><creatorcontrib>VENNUM, Katy</creatorcontrib><creatorcontrib>BRADLEY, Sarah</creatorcontrib><creatorcontrib>WENDER, Richard C</creatorcontrib><creatorcontrib>MINNERS, Regan</creatorcontrib><creatorcontrib>ARNETT, Donna</creatorcontrib><creatorcontrib>American Diabetes Association</creatorcontrib><creatorcontrib>American Cancer Society</creatorcontrib><creatorcontrib>American Heart Association</creatorcontrib><creatorcontrib>on behalf of the American Cancer Society, American Diabetes Association</creatorcontrib><title>Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement</title><title>Diabetes care</title><addtitle>Diabetes Care</addtitle><subject>Biological and medical sciences</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Evidence-Based Practice</subject><subject>Humans</subject><subject>Learning</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Outpatients</subject><subject>Practice Guidelines as Topic</subject><subject>Quality Improvement</subject><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LxDAQhoMouq4e_AOSi6CHatIkbeJtWfyClfWwnktMJlppm5q0gv_eFFeFgRneeXgPD0InlFzmjJVX1lCeEUXoDppRxUQmBJe7aEYoV5lQKj9AhzG-E0I4l3IfHeS8lEqxYob6m0_fjEPtO-wd3rwBvhtrC03dAV7YT90N-hWu8Qpi9F1MW4cOLL4NvsVDotPRDXiV8DgVrMeh10MNKXuC4HxodWcAP4KOY4A25Udoz-kmwvF2z9Hz7c1meZ-t1ncPy8UqM7kkQ2YKDYRKR4wpSSENTEPTTzhZCs1tYawjktJcOQtC6pKC5S8kV5IKbRybo_Of3j74jxHiULV1NNA0ugM_xooKTplkTNGEXvygJvgYA7iqD3Wrw1dFSTUJribB1SQ4safb2vGlBftH_hpNwNkW0NHoxoUkoI7_nBScSJWzb7qrg9c</recordid><startdate>20140601</startdate><enddate>20140601</enddate><creator>BUFALINO, Vincent</creator><creator>BAUMAN, Mary Ann</creator><creator>SHUBROOK, Jay H</creator><creator>BALCH, Alan J</creator><creator>BOONE, Christopher</creator><creator>VENNUM, Katy</creator><creator>BRADLEY, Sarah</creator><creator>WENDER, Richard C</creator><creator>MINNERS, Regan</creator><creator>ARNETT, Donna</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140601</creationdate><title>Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement</title><author>BUFALINO, Vincent ; BAUMAN, Mary Ann ; SHUBROOK, Jay H ; BALCH, Alan J ; BOONE, Christopher ; VENNUM, Katy ; BRADLEY, Sarah ; WENDER, Richard C ; MINNERS, Regan ; ARNETT, Donna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c280t-c6ae018f0cc7068ce8ce81c285f875a4d6cdf081129fde58a71ed4b029815acf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Biological and medical sciences</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Evidence-Based Practice</topic><topic>Humans</topic><topic>Learning</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Outpatients</topic><topic>Practice Guidelines as Topic</topic><topic>Quality Improvement</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BUFALINO, Vincent</creatorcontrib><creatorcontrib>BAUMAN, Mary Ann</creatorcontrib><creatorcontrib>SHUBROOK, Jay H</creatorcontrib><creatorcontrib>BALCH, Alan J</creatorcontrib><creatorcontrib>BOONE, Christopher</creatorcontrib><creatorcontrib>VENNUM, Katy</creatorcontrib><creatorcontrib>BRADLEY, Sarah</creatorcontrib><creatorcontrib>WENDER, Richard C</creatorcontrib><creatorcontrib>MINNERS, Regan</creatorcontrib><creatorcontrib>ARNETT, Donna</creatorcontrib><creatorcontrib>American Diabetes Association</creatorcontrib><creatorcontrib>American Cancer Society</creatorcontrib><creatorcontrib>American Heart Association</creatorcontrib><creatorcontrib>on behalf of the American Cancer Society, American Diabetes Association</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BUFALINO, Vincent</au><au>BAUMAN, Mary Ann</au><au>SHUBROOK, Jay H</au><au>BALCH, Alan J</au><au>BOONE, Christopher</au><au>VENNUM, Katy</au><au>BRADLEY, Sarah</au><au>WENDER, Richard C</au><au>MINNERS, Regan</au><au>ARNETT, Donna</au><aucorp>American Diabetes Association</aucorp><aucorp>American Cancer Society</aucorp><aucorp>American Heart Association</aucorp><aucorp>on behalf of the American Cancer Society, American Diabetes Association</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement</atitle><jtitle>Diabetes care</jtitle><addtitle>Diabetes Care</addtitle><date>2014-06-01</date><risdate>2014</risdate><volume>37</volume><issue>6</issue><spage>1745</spage><epage>1750</epage><pages>1745-1750</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><coden>DICAD2</coden><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>24789936</pmid><doi>10.2337/dc14-0901</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0149-5992 |
ispartof | Diabetes care, 2014-06, Vol.37 (6), p.1745-1750 |
issn | 0149-5992 1935-5548 |
language | eng |
recordid | cdi_proquest_miscellaneous_1541383391 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Biological and medical sciences Diabetes. Impaired glucose tolerance Endocrine pancreas. Apud cells (diseases) Endocrinopathies Evidence-Based Practice Humans Learning Medical sciences Metabolic diseases Outpatients Practice Guidelines as Topic Quality Improvement |
title | Evolution of The Guideline Advantage: Lessons Learned From the Front Lines of Outpatient Performance Measurement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T12%3A15%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%20The%20Guideline%20Advantage:%20Lessons%20Learned%20From%20the%20Front%20Lines%20of%20Outpatient%20Performance%20Measurement&rft.jtitle=Diabetes%20care&rft.au=BUFALINO,%20Vincent&rft.aucorp=American%20Diabetes%20Association&rft.date=2014-06-01&rft.volume=37&rft.issue=6&rft.spage=1745&rft.epage=1750&rft.pages=1745-1750&rft.issn=0149-5992&rft.eissn=1935-5548&rft.coden=DICAD2&rft_id=info:doi/10.2337/dc14-0901&rft_dat=%3Cproquest_cross%3E1541383391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1541383391&rft_id=info:pmid/24789936&rfr_iscdi=true |